Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$73.27 - $83.09 $85,725 - $97,215
1,170 Added 11.31%
11,512 $932,000
Q3 2023

Oct 20, 2023

BUY
$73.94 - $80.67 $256,571 - $279,924
3,470 Added 50.49%
10,342 $775,000
Q2 2023

Jul 24, 2023

BUY
$76.01 - $86.7 $23,563 - $26,877
310 Added 4.72%
6,872 $529,000
Q1 2023

Apr 12, 2023

BUY
$77.31 - $88.08 $83,108 - $94,686
1,075 Added 19.59%
6,562 $544,000
Q4 2022

Jan 19, 2023

BUY
$62.32 - $89.47 $82,013 - $117,742
1,316 Added 31.55%
5,487 $0
Q3 2022

Oct 20, 2022

BUY
$59.54 - $68.01 $27,626 - $31,556
464 Added 12.52%
4,171 $257,000
Q2 2022

Jul 25, 2022

BUY
$57.72 - $65.01 $213,968 - $240,992
3,707 New
3,707 $229,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ellsworth Advisors, LLC Portfolio

Follow Ellsworth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellsworth Advisors, LLC with notifications on news.